Changes related to "Gemcitabine (Gemzar)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 03:33, 21 September 2018
   
Page name:

20 September 2018

 m   16:58  Breast cancer‎‎ (2 changes | history) . . (+1,470). . [Jwarner‎ (2×)]
 m    16:58 (cur | prev) . . (+1,194). . Jwarner (talk | contribs)
 m    16:29 (cur | prev) . . (+276). . Jwarner (talk | contribs) (St Gallen Breast Guidelines)

19 September 2018

 m   22:17  Ovarian cancer‎‎ (4 changes | history) . . (+4,865). . [Jwarner‎ (4×)]
 m    22:17 (cur | prev) . . (+1,552). . Jwarner (talk | contribs) (Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}})
 m    20:00 (cur | prev) . . (+1,262). . Jwarner (talk | contribs) (Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}})
 m    19:47 (cur | prev) . . (+1,337). . Jwarner (talk | contribs) (Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}})
 m    19:39 (cur | prev) . . (+714). . Jwarner (talk | contribs) (Cisplatin & Paclitaxel {{#subobject:d05939|Regimen=1}})

18 September 2018

 m   19:42  Ovarian cancer‎ (diff | hist) . . (+1,947). . Jwarner (talk | contribs) (First-line chemotherapy for advanced/metastatic disease)
 m   11:10  Hodgkin lymphoma‎ (diff | hist) . . (+900). . Jwarner (talk | contribs)

17 September 2018

 m   22:14  Non-small cell lung cancer‎ (diff | hist) . . (+6). . Warner-admin (talk | contribs) (Text replacement - "Subset analysis''':" to "Subgroup analysis:'''")
 m   22:14  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+4). . Warner-admin (talk | contribs) (Text replacement - "'''Subset analysis:'''" to "'''Subgroup analysis:'''")
 m   22:13  Hepatocellular carcinoma‎ (diff | hist) . . (+4). . Warner-admin (talk | contribs) (Text replacement - "'''Subset analysis:'''" to "'''Subgroup analysis:'''")
 m   22:11  Ovarian cancer‎ (diff | hist) . . (+1,359). . Jwarner (talk | contribs) (Carboplatin & Docetaxel {{#subobject:8cd1bc|Regimen=1}})
     21:49  Hodgkin lymphoma‎ (diff | hist) . . (+3,047). . Jwarner (talk | contribs)

16 September 2018

 m   21:43  Hodgkin lymphoma‎‎ (2 changes | history) . . (+687). . [Jwarner‎ (2×)]
 m    21:43 (cur | prev) . . (+1,953). . Jwarner (talk | contribs) (CBV, then auto HSCT {{#subobject:935235|Regimen=1}})
 m    21:37 (cur | prev) . . (-1,266). . Jwarner (talk | contribs) (BEAM, then auto HSCT {{#subobject:ed61ad|Regimen=1}})
 m   16:30  Soft tissue sarcoma‎ (diff | hist) . . (+582). . Jwarner (talk | contribs) (Docetaxel & Gemcitabine {{#subobject:1e718f|Regimen=1}})
 m   16:22  Small cell lung cancer‎ (diff | hist) . . (+1,200). . Jwarner (talk | contribs) (ACE {{#subobject:9fbf31|Regimen=1}})
 m   12:40  Breast cancer‎ (diff | hist) . . (+1,267). . Jwarner (talk | contribs) (Variant #16, 1200/50/1200 x 6 {{#subobject:d46835|Variant=1}})
 m   12:34  Bladder cancer‎‎ (2 changes | history) . . (+33). . [Jwarner‎ (2×)]
 m    12:34 (cur | prev) . . (+17). . Jwarner (talk | contribs)
 m    12:31 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)

15 September 2018

 m   22:47  Hodgkin lymphoma‎‎ (2 changes | history) . . (-407). . [Jwarner‎ (2×)]
 m    22:47 (cur | prev) . . (-423). . Jwarner (talk | contribs) (References)
 m    22:40 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)
 m   11:46  Small cell lung cancer‎ (diff | hist) . . (+15). . Jwarner (talk | contribs) (Variant #2 {{#subobject:531cce|Variant=1}})
 m   11:42  Non-small cell lung cancer‎ (diff | hist) . . (+21). . Warner-admin (talk | contribs) (Regimen {{#subobject:297507|Variant=1}})

14 September 2018

 m   13:36  Non-small cell lung cancer‎ (diff | hist) . . (+280). . Jwarner (talk | contribs)
 m   13:21  Nasopharyngeal carcinoma‎‎ (2 changes | history) . . (+1,236). . [Jwarner‎ (2×)]
 m    13:21 (cur | prev) . . (+626). . Jwarner (talk | contribs) (Cisplatin & RT {{#subobject:c7061f|Regimen=1}})
 m    13:20 (cur | prev) . . (+610). . Jwarner (talk | contribs) (Radiation therapy {{#subobject:5ac377|Regimen=1}})
 m   11:31  Hodgkin lymphoma‎‎ (5 changes | history) . . (+2,435). . [Jwarner‎ (5×)]
 m    11:31 (cur | prev) . . (+29). . Jwarner (talk | contribs) (Investigational agents)
 m    11:22 (cur | prev) . . (+471). . Jwarner (talk | contribs) (Brentuximab vedotin monotherapy {{#subobject:c7e71|Regimen=1}})
 m    11:18 (cur | prev) . . (+1,332). . Jwarner (talk | contribs)
 m    11:08 (cur | prev) . . (+572). . Jwarner (talk | contribs)
 m    11:04 (cur | prev) . . (+31). . Jwarner (talk | contribs)